Studies havent supported any meaningful correlation between changes in taste or food aversions as a result of taking tirzepatide or semaglutide, though there have been anecdotal accounts of this from people who use the medications, Ngo-Hamilton says
Each additional receptor target appears to enhance efficacy but also changes the side effect profile and mechanism of action
The pattern persists across patient subgroups, including those with diabetes, cardiovascular disease, and obesity diagnoses
We cover: Why chasing healthcare superintelligence misses the point How Color uses AI to speed up care and not take over decision-making Their pivot from genetic testing to full-scale clinical delivery How they cut time to treatment in half and boosted screening by 70% Partnering with OpenAI, Memorial Sloan Kettering, and major employers Tune in wherever you listen to podcasts
This limited study can't answer every safety question, especially for newborns or exclusively breastfed babies